---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-23-016209"
form_type: "8-K"
ticker: null
cik: "0001617765"
company_name: "EVOME MEDICAL TECHNOLOGIES INC."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T17:41:44.684270+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Salona Global restructures Biodex debt: cash sweep, 12% interest, forbearance until July 2025

## Summary
- Total outstanding debt $8.26M ($6.76M acquisition debt + $1.5M working capital loan) as of July 25, 2023.
- Forbearance agreement prevents acceleration until July 31, 2025; past due amounts accrue 12% interest.
- Company must pay all cash over $2.5M monthly, 50% of any capital raised, and obtain consent for capex >$100k.
- Working capital loan due Oct 31, 2023; acquisition debt due July 31, 2025.
- Company pursuing $2M ABL facility on Biodex assets to pay down working capital loan.

## SEC filing metadata
- accession: 0001062993-23-016209
- form_type: 8-K
- cik: 0001617765
- company_name: EVOME MEDICAL TECHNOLOGIES INC.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 2.04, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1617765/000106299323016209/0001062993-23-016209-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1617765/000106299323016209/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-23-016209
- JSON: https://secwatch.observer/filing/0001062993-23-016209.json
- Plain text: https://secwatch.observer/filing/0001062993-23-016209.txt

## Key facts
- Debt Financings
  EVOME MEDICAL TECHNOLOGIES INC. reported a default on debt of approximately ten million (US $10,000,000) dollars with Mirion Technologies (US), Inc. at 12% per annum.
  - Principal: approximately ten million (US $10,000,000) dollars
  - Counterparty: Mirion Technologies (US), Inc.
  - Rate: 12% per annum
  - Event: default
  source text: y reported, on April 3, 2023 Salona Global Medical Device Corporation ("Salona") by and through its wholly owned subsidiary Delaware limited liability company, Biodex Rehab Systems, LLC ("Salona Biodex" and together with Salona , the "Company") acquired from Mirion Technologies (US), Inc., a Delaware corporation, ("Mirion") all of the outstanding capital stock of Mirion's subsidiary Biodex Medical Systems, Inc., a New York corporation ("Mirion Biodex" and together with Mirion, the "Seller") in consideration for, among other things, the Company's obligation to pay approximately ten million (US $10,000,000) dollars (the "Debt") to the Seller over time.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1617765/000106299323016209/0001062993-23-016209-index.htm
- Debt Financings
  EVOME MEDICAL TECHNOLOGIES INC. amended debt with Mirion Technologies (US), Inc..
  - Counterparty: Mirion Technologies (US), Inc.
  - Event: amendment
  source text: entered into a Forbearance Agreement (the "Forbearance Agreement") pursuant to which the Seller has agreed to forbear from exercising its rights and remedies against the Company, including the Acceleration Right, through the earlier to occur of (i) the Company's default under the Forbearance Agreement; or (ii) July 31, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1617765/000106299323016209/0001062993-23-016209-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.